29 research outputs found
Bioaktive Kollagenfragmente : Neue strukturbiologische Studien an Kollagen-Integrin-Komplexen belegen Justus Liebigs wegweisende Ideen
In seinem bahnbrechenden Werk Thierchemie von 1843 beschreibt Justus Liebig Ge
latine, das Abbauprodukt von Kollagen, als Leim gebendes Gebilde. Bis heute ist in der Human- wie in der Veterinärmedizin umstritten, ob die Verabreichung von Kollagenfragmenten in Form von Nahrungsergänzungsmitteln eine wirksame Strategie darstellt, um einem Gelenkverschleiß vorzubeugen, der sich z.B. in einer Arthrose manifestieren kann. Die Arbeitsgruppe von Prof. Hans-Christian Siebert kombiniert nanotechnologische Analysemethoden mit Bioinformatikalgorithmen, um die submolekularen Mechanismen zu ergründen, die die hochkomplexen Wechselwirkungen bestimmter Rezeptoren in der extra-zellulären Matrix mit unterschiedlichen bioaktiven Kollagenfragmenten ermöglichen
Transfusion of Target Antigens to Pre-Immunized Recipients:A New Mechanism in Transfusion-Related Acute Lung Injury
Transfusion-related lung injury (TRALI) is a serious side effect of blood transfusion. Exclusion of antibody carriers from the donor pool has significantly decreased the number of cases, but TRALI remains the leading cause of transfusion-related morbidity and mortality in industrialized countries. Here, we show that proteins released from donor cells during processing of blood components are capable of inducing a new type of reverse TRALI when transfused to preimmunized recipients. First, we show that soluble neutrophil surface protein CD177 in complex with proteinase 3 (sCD177/PR3) is not only present in human plasma but also in packed red blood cell (PRBC) supernatant. Filtration or storage enhances the concentration of sCD177/PR3 in PRBCs. Second, we show that sCD177/PR3 specifically binds to PECAM-1 on stimulated (but not on unstimulated) endothelial cells (ECs). Third, we provide evidence that the sCD177/PR3/PECAM-1 complex is functional. In the presence of monoclonal or human antibodies against CD177 or PR3, ECs produce reactive oxygen species and become apoptotic. Albumin flux through an EC monolayer increases significantly whenever antibodies and the cognate antigens are present. Finally, we describe a clinical case in which anti-CD177 present in a transfusion recipient precipitated TRALI after the transfusion of CD177-positive, but not CD177-negative, PRBCs. In conclusion, we introduce a new TRALI mechanism based on the specific binding of transfused, soluble antigens to activated ECs in preimmunized recipients. We suggest that further studies and clinical work-up of TRALI should also include antibody investigation of the recipient
Gauge copies in the Landau-DeWitt gauge: a background invariant restriction
The Landau background gauge, also known as the Landau-DeWitt gauge, has found
renewed interest during the past decade given its usefulness in accessing the
confinement-deconfinement transition via the vacuum expectation value of the
Polyakov loop, describable via an appropriate background. In this Letter, we
revisit this gauge from the viewpoint of it displaying gauge (Gribov) copies.
We generalize the Gribov-Zwanziger effective action in a BRST and background
invariant way; this action leads to a restriction on the allowed gauge
fluctuations, thereby eliminating the infinitesimal background gauge copies.
The explicit background invariance of our action is in contrast with earlier
attempts to write down and use an effective Gribov-Zwanziger action. It allows
to address certain subtleties arising in these earlier works, such as a
spontaneous and thus spurious Lorentz symmetry breaking, something which is now
averted.Comment: 14 pages. v2: version to appear in Phys.Lett.B, with minor
modifications and extra reference
Efficacy of Chondroprotective Food Supplements Based on Collagen Hydrolysate and Compounds Isolated from Marine Organisms †
Osteoarthritis belongs to the most common joint diseases in humans and animals and shows increased incidence in older patients. The bioactivities of collagen hydrolysates, sulfated glucosamine and a special fatty acid enriched dog-food were tested in a dog patient study of 52 dogs as potential therapeutic treatment options in early osteoarthritis. Biophysical, biochemical, cell biological and molecular modeling methods support that these well-defined substances may act as effective nutraceuticals. Importantly, the applied collagen hydrolysates as well as sulfated glucosamine residues from marine organisms were strongly supported by both an animal model and molecular modeling of intermolecular interactions. Molecular modeling of predicted interaction dynamics was evaluated for the receptor proteins MMP-3 and ADAMTS-5. These proteins play a prominent role in the maintenance of cartilage health as well as innate and adapted immunity. Nutraceutical data were generated in a veterinary clinical study focusing on mobility and agility. Specifically, key clinical parameter (MMP-3 and TIMP-1) were obtained from blood probes of German shepherd dogs with early osteoarthritis symptoms fed with collagen hydrolysates. Collagen hydrolysate, a chondroprotective food supplement was examined by high resolution NMR experiments. Molecular modeling simulations were used to further characterize the interaction potency of collagen fragments and glucosamines with protein receptor structures. Potential beneficial effects of collagen hydrolysates, sulfated glycans (i.e., sulfated glucosamine from crabs and mussels) and lipids, especially, eicosapentaenoic acid (extracted from fish oil) on biochemical and physiological processes are discussed here in the context of human and veterinary medicine
Effect of an innovative matrix metalloproteinase-9-antagonists (MMP-9-PEX) on migration and adhesion of colorectal cancer cells
Effect of an innovative matrix metalloproteinase-9-antagonists (MMP-9-PEX) on migration and adhesion of colorectal cancer cells
Transfusion of Soluble Target Antigens to Pre-Immunized Recipients:A Previously Overlooked Mechanism in Transfusion-Related Acute Lung Injury
Hepatocyte integrity depends on c-Jun-controlled proliferation in Schistosoma mansoni infected mice
Abstract Schistosomiasis is a parasitic disease affecting more than 250 million people worldwide. The transcription factor c-Jun, which is induced in S. mansoni infection-associated liver disease, can promote hepatocyte survival but can also trigger hepatocellular carcinogenesis. We aimed to analyze the hepatic role of c-Jun following S. mansoni infection. We adopted a hepatocyte-specific c-Jun knockout mouse model (Alb-Cre/c-Jun loxP) and analyzed liver tissue and serum samples by quantitative real-time PCR array, western blotting, immunohistochemistry, hydroxyproline quantification, and functional analyses. Hepatocyte-specific c-Jun knockout (c-JunΔli) was confirmed by immunohistochemistry and western blotting. Infection with S. mansoni induced elevated aminotransferase-serum levels in c-JunΔli mice. Of note, hepatic Cyclin D1 expression was induced in infected c-Junf/f control mice but to a lower extent in c-JunΔli mice. S. mansoni soluble egg antigen-induced proliferation in a human hepatoma cell line was diminished by inhibition of c-Jun signaling. Markers for apoptosis, oxidative stress, ER stress, inflammation, autophagy, DNA-damage, and fibrosis were not altered in S. mansoni infected c-JunΔli mice compared to infected c-Junf/f controls. Enhanced liver damage in c-JunΔli mice suggested a protective role of c-Jun. A reduced Cyclin D1 expression and reduced hepatic regeneration could be the reason. In addition, it seems likely that the trends in pathological changes in c-JunΔli mice cumulatively led to a loss of the protective potential being responsible for the increased hepatocyte damage and loss of regenerative ability
The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s Disease
The accumulation and aggregation of alpha-synuclein (α-Syn) are pathological processes associated with Parkinson's disease, indicating that the regulation of protein is a crucial etiopathological mechanism. Interestingly, human serum and cerebrospinal fluid contain autoantibodies that recognize α-Syn. This potentially demonstrates an already existing, naturally decomposing, and protective system. Thus, quantitative or qualitative alterations, such as the modified antigen binding of so-called naturally occurring autoantibodies against α-Syn (nAbs-α-Syn), may induce disease onset and/or progression. We investigated the serum titers and binding characteristics of nAbs-α-Syn in patients suffering from sporadic Parkinson's disease (n = 38), LRRK2 mutation carriers (n = 25), and healthy controls (n = 22)